Which stocks in any sector do Indian mutual fund managers prefer most? — September 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 473 funds | 2.53% | ₹60,584 Cr |
| 2 | Divi's Laboratories Limited | 368 funds | 2.61% | ₹34,638 Cr |
| 3 | Torrent Pharmaceuticals Limited | 345 funds | 2.06% | ₹14,787 Cr |
| 4 | Cipla Limited | 296 funds | 1.53% | ₹22,986 Cr |
| 5 | Dr. Reddy's Laboratories Limited | 278 funds | 1.51% | ₹18,504 Cr |
| 6 | Lupin Limited | 229 funds | 1.50% | ₹12,976 Cr |
| 7 | Aurobindo Pharma Limited | 219 funds | 1.69% | ₹10,221 Cr |
| 8 | Mankind Pharma Limited | 217 funds | 1.18% | ₹11,966 Cr |
| 9 | Glenmark Pharmaceuticals Limited | 208 funds | 1.33% | ₹8,230 Cr |
| 10 | Laurus Labs Limited | 202 funds | 2.85% | ₹8,569 Cr |
| 11 | Ajanta Pharma Limited | 196 funds | 1.00% | ₹8,098 Cr |
| 12 | Biocon Limited | 186 funds | 0.98% | ₹13,199 Cr |
| 13 | Zydus Lifesciences Limited | 184 funds | 1.12% | ₹6,275 Cr |
| 14 | Alkem Laboratories Limited | 183 funds | 1.25% | ₹12,151 Cr |
| 15 | Sai Life Sciences Limited | 177 funds | 1.89% | ₹9,721 Cr |
| 16 | Gland Pharma Limited | 172 funds | 1.87% | ₹14,125 Cr |
| 17 | Abbott India Limited | 167 funds | 0.94% | ₹4,508 Cr |
| 18 | Acutaas Chemicals Ltd | 166 funds | 1.81% | ₹3,932 Cr |
| 19 | Anthem Biosciences Limited | 163 funds | 0.68% | ₹4,577 Cr |
| 20 | IPCA Laboratories Limited | 161 funds | 1.21% | ₹15,536 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of September 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.